Am J Transplant, Volume 5, Suppl 3 Archives - Page 115 of 170 - ATC Abstracts

2015 American Transplant Congress
Results from the Use of Aortohepatic Conduit in Orthotopic Liver Transplantation: A Single Centre 12-Year Experience
M. Aly, N. Chatzizacharias, A. Gimson, E. Huguet, A. Butler, C. Watson, G. Pettigrew, A. Jah, N. Jamieson, R. Praseedom.
Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom.
Our study investigates the outcomes of the use of aortohepatic conduits in OLT.Methods: This is a retrospective single centre analysis of prospectively collected data from…
2015 American Transplant Congress
Kidneys from Living Donors With High Body Mass Index Do Not Have Inferior Outcomes
K. Koutroutsos, S. Chong, D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The disparity between donor kidney availability and demand has increased utilization of kidneys from marginal living donors. Data regarding outcome of transplantation from living donors…
2015 American Transplant Congress
Live Kidney Donor Evaluation: Association of Race With Ineligibility
K. Kumar, A. Poon, A. Massie, A. Muzaale, T. Purnell, J. Tonascia, E. King, D. Segev.
Johns Hopkins, Baltimore.
Background: African American (AA) waitlist candidates face many barriers to identifying LKDs. However, even if AA candidates identify a potential donor, it is unclear whether…
2015 American Transplant Congress
The Impact of Center Size on Outcome of Pancreas Transplants
A. Gruessner,¹ R. Gruessner.²
¹Colllege of Pubkic Health, University of Arizona, Tucson, AZ; ²Department of Surgery, University of Arizona, Tucson, AZ.
Introduction: The number of pancreas transplants (PxTx) has continuously declined over the last decade. Since the number of transplant centers that perform pancreas transplants has…
2015 American Transplant Congress
Allograft Pancreatectomy: Indications and Outcomes
S. Nagai, J. Powelson, R. Mangus, J. Fridell.
Transplant Surgery, Indiana University School of Medicine, Indianapolis, IN.
Background: Indications for allograft pancreatectomy have not been clearly established, but cause and timing of graft loss, clinical symptoms and candidacy for pancreas retransplantation are…
2015 American Transplant Congress
Patient Self-Reported Adherence to and Perceptions Towards Immunosuppressive Medications at the Outpatient Renal Transplant Clinic at St. Joseph's Healthcare Hamilton (SJHH)
K. Kak,¹ C. Burger,¹ D. Treleaven,² C. Wallace.¹
¹Pharmacy, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada; ²Medicine, McMaster University, Hamilton, ON, Canada.
Objectives To gain insight into the immunosuppressant adherence of patients followed by the Outpatient Renal Transplant Clinic at St. Joseph's Healthcare Hamilton (SJHH) and to…
2015 American Transplant Congress
Dietary-Associated Trimethylamine N-Oxide (TMAO) Levels Is associated With Coronary Allograft Vasculopathy Following Heart Transplantation
S. Zeltzer,¹ Z. Wang,¹ M. Askar,² J. Coughlin,¹ T. Hudec,¹ D. Taylor,³ L. Li,¹ R. Starling,³ S. Hazen,¹ W. Tang.¹
¹Cellular and Molecular Medicine, Cleveland Clinic, Cleveland, OH; ²Transplant Center, Cleveland Clinic, Cleveland, OH; ³Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
Background: Coronary allograft vasculopathy (CAV) is a leading cause of cardiac graft failure after 1 year post transplant. It is characterized by an inflammatory vascular…
2015 American Transplant Congress
Chimeric Patients Who Undergo Combined Facilitating Cell-Enriched/HSC/Renal Transplant Exhibit Robust TCR Repertoire
I. Konieczna,¹ J. Mathew,¹ J. Miller,¹ S. Ildstad,^2,3 J. Leventhal.¹
¹Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL; ²Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; ³Regenerex, LLC, Louisville, KY.
Combined donor kidney plus facilitating cell enriched hematopoietic stem cell (FCRx) transplants (Tx), after low intensity conditioning with fludarabine, 200-cGy total body irradiation and cyclophosphamide…
2015 American Transplant Congress
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to Assess the Risk of Acute Subclinical Rejection After Kidney Transplantation
O. Bestard,^1,2 E. Crespo,¹ T. Sigdel,² S. Roedder,² Y. Ng,² J. Cruzado,¹ M. Lúcia,¹ S.-C. Hsieh,¹ T. Tran,¹ J. Grinyó,¹ M. Sarwal.¹
¹Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, CAT, Spain; ²Department of Transplant Surgery, UCSF, San Francisco, CA.
Subclinical allograft rejection (sc-AR) is still a main cause of allograft loss that can only be assessed through invasive surveillance biopsies. We sought to investigate…
2015 American Transplant Congress
Ischemia Reperfusion Injury in Orthotopic Liver Transplantation Primes the Adaptive Immune Response and Generation of Proinflammatory Cytokines
A. Zarrinpar,¹ P. Rao,² C. Lassman,² V. Agopian,¹ F. Kaldas,¹ D. Farmer,¹ R. Busuttil,¹ Y. Zhai,¹ J. Kupiec-Weglinski,¹ E. Reed.²
¹Surgery, University of California, Los Angeles, Los Angeles, CA; ²Pathology and Lab Medicine, University of California, Los Angeles, Los Angeles, CA.
Background: Transplanted organs are exquisitely susceptible to effects of ischemia/reperfusion injury (IRI), an immune-mediated process that occurs during transplantation and beyond. Recipient and graft outcomes,…